Screener
Veracyte VCYT Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Intangible asset amortization - operating expenses | 579 | 622 |
| Total operating expenses | 78,513 | 76,604 |
| Income from operations | 22,646 | 2,904 |
| Other income, net | 7,328 | 4,524 |
| Income before income taxes | 29,974 | 7,428 |
| Income tax provision | 1,267 | 381 |
| Net income | $28,707 | $7,047 |
| Earnings per share: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's other income (expense)?
- Veracyte (VCYT) reported other income (expense) of $7.33M in Q1 2026.
- How has Veracyte's other income (expense) changed year-over-year?
- Veracyte's other income (expense) increased by 62.0% year-over-year, from $4.52M to $7.33M.
- What is the long-term trend for Veracyte's other income (expense)?
- Over 4 years (2021 to 2025), Veracyte's other income (expense) has grown at a 153.1% compound annual growth rate (CAGR), from $254K to $10.42M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Veracyte's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude